MedTrace Logo

Use of Antibiotic Based Irrigation for Ureteroscopic Treatment of Urolithiasis

NCT06007352 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2025-01-16

No results posted yet for this study

Summary

The purpose of the study is to investigate whether the use of gentamicin-based irrigation fluid during ureteroscopy decreases the risk of UTIs and other post-operative infections after surgery.

Conditions

Interventions

DRUG

Gentamicin

Participants will be given 120 mg of gentamicin infused in 3 L NaCl used in irrigation for ureteroscopy

OTHER

Placebo

3 L of NaCl irrigation typically used for ureteroscopy surgery

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Piruz Motamedinia, M.D. · Yale School of Medicine, Department of Urology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-10-31
Completion
2025-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06007352 on ClinicalTrials.gov